VYNE Therapeutics Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2017 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
VYNE Therapeutics Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2017 to Q1 2025.
  • VYNE Therapeutics Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$11.5M, a 43.6% decline year-over-year.
  • VYNE Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$34M, a 34.1% decline from 2023.
  • VYNE Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$25.3M, a 13.2% increase from 2022.
  • VYNE Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$29.2M, a 48.2% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$11.5M -$3.48M -43.6% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q1 2024 -$7.98M -$2.5M -45.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q1 2023 -$5.48M +$3.56M +39.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 -$9.04M +$3.51M +28% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 -$12.6M +$39.7M +76% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 -$52.2M -$35.6M -214% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 -$16.6M -$5.44M -48.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 -$11.2M -$5.62M -101% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q1 2017 -$5.58M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.